EXAS vs IONS · rev $2.76B vs rev $514.0M
EXACT Sciences Corporation (EXAS) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
EXAS currently screens at market cap $20.03B. IONS currently screens at market cap $12.28B.
Not investment advice. Open the EXAS and IONS stock pages for the full models.
Not investment advice.